Lexicon Pharmaceuticals (LXRX) Accumulated Expenses: 2009-2011
Historic Accumulated Expenses for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $13.8 million.
- Lexicon Pharmaceuticals' Accumulated Expenses rose 65.94% to $12.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $12.8 million, marking a year-over-year increase of 65.94%. This contributed to the annual value of $13.8 million for FY2011, which is 120.08% up from last year.
- Lexicon Pharmaceuticals' Accumulated Expenses amounted to $13.8 million in FY2011, which was up 120.08% from $6.3 million recorded in FY2010.
- Lexicon Pharmaceuticals' 5-year Accumulated Expenses high stood at $13.8 million for FY2011, and its period low was $5.6 million during FY2009.
- Its 3-year average for Accumulated Expenses is $8.6 million, with a median of $6.3 million in 2010.
- Data for Lexicon Pharmaceuticals' Accumulated Expenses shows a peak YoY soared of 120.08% (in 2011) over the last 5 years.
- Yearly analysis of 3 years shows Lexicon Pharmaceuticals' Accumulated Expenses stood at $5.6 million in 2009, then climbed by 11.64% to $6.3 million in 2010, then spiked by 120.08% to $13.8 million in 2011.